Navigation Links
Spiral Enteroscopy is Three Times Faster than Double-Balloon Enteroscopy in Diagnosing the Small Intestine, New Study Finds
Date:5/3/2010

NEW ORLEANS, May 3 /PRNewswire/ -- Spirus Medical, Inc., a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, announced at Digestive Disease Week 2010 that results from the first-ever prospective study comparing enteroscopy technologies show spiral enteroscopy (SE) to be more than three times faster, on average, than double-balloon enteroscopy (DBE) in examining the small intestine.

Average total examination time was only 27 minutes when performed with spiral enteroscopy, versus 86 minutes with DBE.

Led by Dr. Andreas Adler of the Charite Medical University of Berlin and colleagues from the University Medical Center Hamburg-Eppendorf, the study of 42 patients was conducted from August 2008 to September 2009.  Patients were prospectively randomized and evaluated on the simplicity, safety and efficiency of spiral enteroscopy compared to double-balloon enteroscopy.  Twenty patients were examined with SE (15 oral, 5 anal), and 22 patients were examined with DBE (16 oral, 6 anal).  

The study also found positioning with SE to be more stable than DBE when used to collect samples from the small bowel or to perform therapy.  Similar insertion depths were achieved with the two procedures, with SE and DBE on average reaching 284 centimeters and 272 cm, respectively, between the Ligament of Treitz and the ileocecal valve.  Patients under both procedures showed the same level of relative comfort during exams.  Findings were presented at this year's German Society for Endoscopy & Imaging conference in Hannover.

Indications for enteroscopy of the small intestine are rising mainly due to findings from capsule endoscopy, a diagnostic-only  procedure.  However, reaching the deep ileum with an endoscope had been a challenge.  The Spirus Endo-EaseDiscovery® SB system is an overtube with an outer spiral that has been in use worldwide since 2008.  The product's patented spiral feature promotes easier advancement of an endoscope, which helps physicians examine and treat upper and lower GI disorders.  

"This first-ever prospective study shows clearly that spiral enteroscopy can achieve the same insertion depths as DBE but much more quickly, which means higher efficiency  for physicians and a better treatment experience for patients," said Dr. Adler.  "Spirus' Endo-Ease Discovery SB system is not only meeting but overcoming the challenges endoscopists have traditionally faced when evaluating the small bowel."

Spirus Medical is exhibiting at Digestive Disease Week for the fourth straight year, and in addition to Endo-Ease Discovery SB will also be showcasing its latest technology, including a self-advancing endoscope.  Spirus is located at booth #2235.

Spirus Medical, Inc., headquartered in Stoughton, Mass., was incubated and founded in 2005 by STD Med, Inc., a Stoughton-based manufacturer and developer of medical technologies.    For more on Spirus Medical, visit spirusmed.com


'/>"/>
SOURCE Spirus Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... injectable drug delivery systems, today announced that it will release ... December 31, 2015 after market close on February 9, 2016. ... call to discuss these financial results.    About ... --> About Unilife Corporation ...
(Date:2/8/2016)... NORTHBROOK, Ill. , Feb. 8, 2016  Astellas Pharma ... today announced the promotion of James Robinson as ... the company,s operations in North and South America ... president, Astellas Pharma US, representing the commercial organization in ... assumed in 2013. Masao Yoshida , who ...
(Date:2/8/2016)... Palatin Technologies, Inc. (NYSE MKT: PTN), ... for the treatment of diseases with significant unmet ... the United States Patent and Trademark Office (USPTO) ... Patent Application Serial Number 14/313,258 (the ,258 application).  ... female sexual dysfunction using the formulation and dose ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try ... Clay” the health benefits of integrating clay into a daily diet are numerous, as ... motivational speaker, Perry A~ has since dedicated her life to learning about the benefits ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
Breaking Medicine News(10 mins):